Treosulfan

The following clinically significant adverse reactions are described elsewhere in the labeling:

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: The following clinically significant adverse reactions are described elsewhere in the labeling:
Do not take if: GRAFAPEX is contraindicated in patients with hypersensitivity to any component of the drug product.

Side effects, and when to stop

Myelosuppression
Seizures
Skin Disorders
Injection Site Reactions and Tissue Necrosis
Secondary Malignancies

Who should not take it

GRAFAPEX is contraindicated in patients with hypersensitivity to any component of the drug product.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Treosulfan; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/treosulfan
APA 7th: sofidex. (2026, August 3). Treosulfan. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/treosulfan
AMA 11th: Treosulfan. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/treosulfan

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.